Retatrutide – 30mg (3 Pack)

Retatrutide is a next-generation triple-agonist peptide that simultaneously
activates GLP-1, GIP, and glucagon receptors.
Its multi-pathway activity makes it a major focus in metabolic research for
obesity, glycemic regulation, and energy expenditure.
This 3 pack of 30mg vials provides a total of 90mg, ideal for extended or large-scale laboratory studies.

Potential Research Benefits

• Explored for weight management & appetite regulation
• Studied for glucose control & insulin sensitivity
• Supports lipid metabolism & energy expenditure research
• Triple-receptor activity: GLP-1, GIP & glucagon

Scientific Background

Retatrutide’s triple mechanism distinguishes it from single- and dual-agonist incretin compounds.
Early findings suggest synergistic benefits for reducing body weight, improving insulin response,
and regulating lipid metabolism.
With its ability to simultaneously engage GLP-1, GIP, and glucagon receptors,
Retatrutide represents one of the most advanced investigational peptides in metabolic research.

Product Details

• Compound: Retatrutide
• Form: Lyophilized Powder
• Amount: 30mg per vial
• Pack Size: 3 vials (30mg each)
• Total Peptide: 90mg
• Purity: ≥99%
• Appearance: White to off-white powder
• Manufactured: USA | Third-party tested
• Research Use Only: Not for human consumption